- Home
- AMRX vs BBU Comparison
AMRX vs BBU Comparison
Compare AMRX & BBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- BBU
- Stock Information
- Founded
- AMRX 2002
- BBU 2016
- Country
- AMRX United States
- BBU Bermuda
- Employees
- AMRX N/A
- BBU N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- BBU Engineering & Construction
- Sector
- AMRX Health Care
- BBU Consumer Discretionary
- Exchange
- AMRX Nasdaq
- BBU Nasdaq
- Market Cap
- AMRX 2.5B
- BBU 2.3B
- IPO Year
- AMRX N/A
- BBU N/A
- Fundamental
- Price
- AMRX $9.39
- BBU $24.85
- Analyst Decision
- AMRX Strong Buy
- BBU Buy
- Analyst Count
- AMRX 4
- BBU 5
- Target Price
- AMRX $11.50
- BBU $31.80
- AVG Volume (30 Days)
- AMRX 1.5M
- BBU 27.8K
- Earning Date
- AMRX 08-05-2025
- BBU 08-01-2025
- Dividend Yield
- AMRX N/A
- BBU 1.02%
- EPS Growth
- AMRX N/A
- BBU N/A
- EPS
- AMRX 0.01
- BBU N/A
- Revenue
- AMRX $2,852,914,000.00
- BBU $30,103,000,000.00
- Revenue This Year
- AMRX $9.92
- BBU N/A
- Revenue Next Year
- AMRX $7.39
- BBU $4.96
- P/E Ratio
- AMRX $853.53
- BBU N/A
- Revenue Growth
- AMRX 9.81
- BBU N/A
- 52 Week Low
- AMRX $6.69
- BBU $18.63
- 52 Week High
- AMRX $9.48
- BBU $27.47
- Technical
- Relative Strength Index (RSI)
- AMRX 77.19
- BBU 47.84
- Support Level
- AMRX $7.98
- BBU $24.18
- Resistance Level
- AMRX $8.57
- BBU $25.83
- Average True Range (ATR)
- AMRX 0.27
- BBU 0.82
- MACD
- AMRX 0.15
- BBU -0.02
- Stochastic Oscillator
- AMRX 98.85
- BBU 57.25
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About BBU Brookfield Business Partners L.P. Limited Partnership Units
Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.